• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染、血管生成、重塑——干细胞是颌骨骨病的答案吗?

Infection, vascularization, remodelling--are stem cells the answers for bone diseases of the jaws?

出版信息

Head Face Med. 2011 Feb 18;7:5. doi: 10.1186/1746-160X-7-5.

DOI:10.1186/1746-160X-7-5
PMID:21332971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3055822/
Abstract

Osteonecrosis after craniofacial radiation (ORN), osteomyelitis and bisphosphonates related necrosis of the jaw (BRONJ) are the predominant bone diseases in Cranio- and Maxillofacial surgery. Although various hypothesis for the pathophysiological mechanisms including infection, altered vascularisation or remodelling exist, the treatment is still a challenge for clinicians. As the classical pharmacological or surgical treatment protocols have only limited success, stem cells might be a promising treatment option, indicated by recently published data.

摘要

颅颌面放射治疗后骨坏死(ORN)、骨髓炎和双膦酸盐相关颌骨坏死(BRONJ)是颅颌面外科中主要的骨病。尽管存在包括感染、血管改变或重塑等多种病理生理机制的假设,但治疗仍然是临床医生面临的挑战。由于经典的药物治疗或手术治疗方案效果有限,因此最近发表的数据表明,干细胞可能是一种有前途的治疗选择。

相似文献

1
Infection, vascularization, remodelling--are stem cells the answers for bone diseases of the jaws?感染、血管生成、重塑——干细胞是颌骨骨病的答案吗?
Head Face Med. 2011 Feb 18;7:5. doi: 10.1186/1746-160X-7-5.
2
Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.采用慢性化脓性骨髓炎治疗方案治疗低、中效双膦酸盐相关颌骨骨坏死:7例报告
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Feb;107(2):e1-7. doi: 10.1016/j.tripleo.2008.09.021. Epub 2008 Dec 13.
3
Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice.基于细胞的间充质干细胞免疫疗法可治愈小鼠的双膦酸盐相关性颌骨坏死样疾病。
J Bone Miner Res. 2010 Jul;25(7):1668-79. doi: 10.1002/jbmr.37.
4
Recent Clinical Evidence in Bisphosphonate-related Osteomyelitis of the Jaw: Focus on Risk, Prevention and Treatment.双膦酸盐相关颌骨骨髓炎的最新临床证据:聚焦于风险、预防与治疗
Rev Recent Clin Trials. 2014;9(1):37-52. doi: 10.2174/1574887109666140423120614.
5
Bisphosphonate related osteonecrosis of the jaws: spontaneous or dental origin?双膦酸盐相关性颌骨骨坏死:自发性还是牙科源性?
Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Sep;116(3):287-92. doi: 10.1016/j.oooo.2013.05.005.
6
Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update.静脉注射双膦酸盐(BRONJ)治疗患者的颌骨骨坏死:简要更新。
Oral Oncol. 2009 Jul;45(7):551-4. doi: 10.1016/j.oraloncology.2009.01.002. Epub 2009 Feb 28.
7
Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review.双膦酸盐相关颌骨坏死:综述
J Oral Pathol Med. 2007 Jul;36(6):319-28. doi: 10.1111/j.1600-0714.2007.00540.x.
8
Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction.拔牙术后双膦酸盐相关颌骨骨坏死的发生情况。
J Oral Maxillofac Surg. 2010 Apr;68(4):797-804. doi: 10.1016/j.joms.2009.10.026.
9
Jaw osteonecrosis related to bisphosphonate therapy: a severe secondary disorder.与双膦酸盐治疗相关的颌骨坏死:一种严重的继发性疾病。
Bone. 2007 Apr;40(4):828-34. doi: 10.1016/j.bone.2006.11.023. Epub 2007 Jan 22.
10
The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.双膦酸盐相关颌骨坏死的发病机制:假说众多,数据匮乏。
J Oral Maxillofac Surg. 2009 May;67(5 Suppl):61-70. doi: 10.1016/j.joms.2009.01.007.

引用本文的文献

1
Cell therapy stimulates bone neoformation in calvaria defects in rats subjected to local irradiation.细胞疗法可刺激局部照射大鼠颅骨缺损处的骨新生。
Animal Model Exp Med. 2019 Jul 1;2(3):169-177. doi: 10.1002/ame2.12073. eCollection 2019 Sep.
2
Adipose-Derived Stromal Cells Are Capable of Restoring Bone Regeneration After Post-Traumatic Osteomyelitis and Modulate B-Cell Response.脂肪来源的基质细胞能够在创伤性骨髓炎后恢复骨再生,并调节 B 细胞反应。
Stem Cells Transl Med. 2019 Oct;8(10):1084-1091. doi: 10.1002/sctm.18-0266. Epub 2019 Jun 10.
3
Treatment of stage II medication-related osteonecrosis of the jaw with necrosectomy and autologous bone marrow mesenchymal stem cells.采用坏死骨切除术和自体骨髓间充质干细胞治疗II期药物相关性颌骨坏死。
Odontology. 2017 Oct;105(4):484-493. doi: 10.1007/s10266-017-0295-4. Epub 2017 Feb 20.
4
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw.自体骨髓干细胞病灶内移植修复双膦酸盐相关性颌骨骨坏死。
Head Face Med. 2011 Aug 17;7:16. doi: 10.1186/1746-160X-7-16.

本文引用的文献

1
Human BM stem cells initiate angiogenesis in human islets in vitro.人骨髓基质干细胞在体外诱导人胰岛血管生成。
Bone Marrow Transplant. 2011 Aug;46(8):1128-37. doi: 10.1038/bmt.2010.278. Epub 2010 Dec 6.
2
Comparison of ectopic bone formation of embryonic stem cells and cord blood stem cells in vivo.体内比较胚胎干细胞和脐血干细胞异位成骨的情况。
Tissue Eng Part A. 2010 Aug;16(8):2475-83. doi: 10.1089/ten.TEA.2009.0546.
3
Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice.基于细胞的间充质干细胞免疫疗法可治愈小鼠的双膦酸盐相关性颌骨坏死样疾病。
J Bone Miner Res. 2010 Jul;25(7):1668-79. doi: 10.1002/jbmr.37.
4
Osteoradionecrosis of the jaws--a current overview--part 1: Physiopathology and risk and predisposing factors.颌骨放射性骨坏死——当前综述——第1部分:病理生理学及风险和易感因素
Oral Maxillofac Surg. 2010 Mar;14(1):3-16. doi: 10.1007/s10006-009-0198-9.
5
The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.双膦酸盐相关颌骨坏死的发病机制:假说众多,数据匮乏。
J Oral Maxillofac Surg. 2009 May;67(5 Suppl):61-70. doi: 10.1016/j.joms.2009.01.007.
6
Bisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bench.双膦酸盐与颌骨坏死:从临床到实验研究
Cells Tissues Organs. 2009;189(1-4):289-94. doi: 10.1159/000151371. Epub 2008 Aug 13.
7
Induction of osteogenic markers in differentially treated cultures of embryonic stem cells.胚胎干细胞不同处理培养物中成骨标志物的诱导
Head Face Med. 2008 Jun 10;4:10. doi: 10.1186/1746-160X-4-10.
8
Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome.口服双膦酸盐类药物所致颌骨骨坏死:发病率、临床特征、易感因素及治疗结果
Osteoporos Int. 2007 Oct;18(10):1363-70. doi: 10.1007/s00198-007-0384-2. Epub 2007 Jun 28.
9
Recent advances in understanding the mechanism of action of bisphosphonates.双膦酸盐作用机制研究的最新进展。
Curr Opin Pharmacol. 2006 Jun;6(3):307-12. doi: 10.1016/j.coph.2006.03.005. Epub 2006 May 2.
10
Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.双膦酸盐化合物唑来膦酸的新型抗血管生成作用。
J Pharmacol Exp Ther. 2002 Sep;302(3):1055-61. doi: 10.1124/jpet.102.035295.